C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses

Parasite Immunology

Volumn 24, Issue 9-10, 2002, Pages 447-454

  Bodman Smith, Katherine B ^a   Mbuchi, Margaret ^a   Culley, Fiona J ^a   Bates, Paul A ^b   Raynes, John G ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

CRP; L. donovani; Macrophage; Phagocytosis

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT; FC RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; PHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BLOOD; CELL DIFFERENTIATION; CELL STRAIN U937; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ERYTHROCYTE; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEISHMANIA DONOVANI; LEISHMANIASIS; LIQUID; MACROPHAGE ACTIVATION; NONHUMAN; OPSONIZATION; PARASITE SURVIVAL; PARASITE VIRULENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMASTIGOTE; STATISTICAL SIGNIFICANCE;

ANIMALS; C-REACTIVE PROTEIN; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGE ACTIVATION; MACROPHAGES; OPSONIN PROTEINS; PHAGOCYTOSIS; U937 CELLS;

ANIMALIA; LEISHMANIA DONOVANI; MAMMALIA; PROTOZOA;

EID: 0036767872     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2002.00486.x     Document Type: Article

References (46)

1. Wilson ME, Pearson RD. Evidence that Leishmania donovani utilises a mannose receptor on human mononuclear phagocytes to establish intracellular infection. J Immunol 1986; 136: 4681-4688.
2. Wilson ME, Pearson RD. Roles of CR3 and mannnose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect Immun 1988; 56: 3639-3639.
3. Rivzi FS, Ouaissi MA, Marty B, Santoro F, Capron A. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. Eur J Immunol 1988; 18: 473-476.
4. Mosser DM, Edelson PJ. Activation of the alternative complement pathway by Leishmania promastigotes; parasite lysis and attachment to macrophages. J Immunol 1984; 132: 1501-1505.
5. Peters C, Aebischer A, Stiehorf YD, Fuchs M, Overath P. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. J Cell Sci 1995; 108: 3715-3724.
6. Culley FJ, Harris RA, Kaye PM, McAdam PWJ, Raynes JG. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J Immunol 1996; 156: 4691-4696.
7. Bodman-Smith KB, Melendez AJ, Campbell I, Harrison PT, Allen JM, Raynes JG. C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI). Immunol 2002; 107: 252-260.
8. Kima PE, Constant SL, Hannum L et al. Internalisation of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 2000; 191: 1063-1067.
9. Guy RA, Bolosevic M. Comparson of receptors required for entry of Leishmania major amastigotes by macrophages. Infect Immunol 1993; 61: 1553-1558.
10. Mosser DM, Edelson PJ. The third component of complement is responsible for the intracellular survival of Leishmania major. Nature 1987; 327: 329-331.
11. Wright SD, Silverstein SC. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 1989; 158: 2016-2023.
12. Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA. Leishmania major amastigotes initiate the 1-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 1990; 145: 4290-4297.
13. Liew FY, Li Y, Millott S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990; 145: 4306-4310.
14. Murray HW, Nathan CF. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 1999; 189: 741-746.
15. Frankenburg S, Leibovici V, Mansbach N, Turco SJ, Rosen G. Effect of glycolipids of Leishmania parasites on monocyte activity. J Immunol 1990; 145: 4284-4289.
16. Proudfoot L, O'Donnell CA, Liew FY. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmaniacidal activity in murine macrophages. Eur J Immunol 1995; 25: 745-750.
17. Russell DG, Talamas-Rohana P. Leishmania and the macrophage, a marriage of inconvenience. Immunol Today 1989; 10: 328-333.
18. Mold C, Nakayama S, Holzer TJ, Gewurz H, Du Clos TW. CRP is protective against Streptococcus pneumoniae in mice. J Exp Med 1981; 154: 1703-1708.
19. Mortensen RF, Zhong W. Regulation of phagocytic leukocyte activities by C-reactive protein. J Leukocyte Biol 2000; 67: 495-500.
20. Chudwin D, Artrip SG, Korenblit A, Schiffman G, Rao S. Correlation with serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae. Infect Immun 1985; 50: 213-217.
21. Szalai AJ, Briles DE, Volanakis JE. Role of complement in C-reactive protein-mediated protection of mice from Streptococcus pneumoniae. Infect Immun 1996; 64: 4850-4853.
22. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-54.
23. Kushner I, Kaplan MH. Studies of acute phase proteins. I. An immunohistochemical method for the localisation of CRP in rabbits. Association with necrosis in local inflammatory lesions. J Exp Med 1961; 114: 961-979.
24. Pepys MB, Booth SE, Tennet GA, Butler PJG, Williams DG. Binding of pentraxins to different nuclear structures. CRP binds to small nuclear ribonuclearprotein particles and serum amyloid P binds to chromatin and nucleoli. Clin Exp Immunol 1994; 97: 152-157.
25. Kew RR, Hyers TM, Webster RO. Human CRP inhibits neutrophil chemotaxis in vitro; possible implications for ARDS. J Lab Clin Med 1990; 115: 339-345.
26. Ahmed N, Thorley R, Xia D, Samols D, Webster RO. Transgenic mice expressing CRP exhibit diminished chemotactic factor induced alveolitis. Am J Resp Crit Care Med 1996; 153: 1141-1147.
27. Culley FJ, Bodman-Smith KB, Ferguson MAJ, Nikolaev AV, Shantilal N, Raynes JG. C-reactive protein binds to phosphorylated carbohydrates. Glycobiology 2000; 10: 59-65.
28. Bee A, Culley FJ, Alkhalife IS, Bodman-Smith KB, Raynes JG, Bates PA. Transformation of Leishmania mexicana metacyclic promastigotes to amastigote-like forms mediated by binding of C-reactive protein. Parasitology 2001; 122: 521-529.
29. Pasceri V, Willerson JT, Yeh ET. Direct pro-inflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
30. Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. Modulation of C-reactive protien-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001; 103: 2531-2534.
31. Ratnam S, Mookerjea S. The regulation of superoxide generation and nitric oxide synthase by CRP. Immunology 1998; 94: 560-568.
32. Miyagawa N, Okamoto Y, Nakano H. Effect of C-reactive protein on peritoneal macrophages. II. Human C-reactive protein activates peritoneal macrophages of guinea pigs to release superoxide anion in vitro. Microbiol Immunol 1988; 32: 721-723.
33. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992; 4: 361-368.
34. Galve-d, e-Rochemonteix B, Wiktorowicz K, Kushner I, Dayer JM. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukocyte Biol 1993; 53: 439-445.
35. Marnell L, Mold C, Volzer MA, Burlingame RW, Du Clos TW. CRP binds to FcγRI in transfected cos cells. J Immunol 1995; 155: 2185-2193.
36. Stein MP, Edberg JC, Kimberley PP et al. CRP binding to FcγRIIa on human monocytes and neutrophils is allele specific. J Clin Invest 2000; 105: 369-376.
37. Volanakis JE, Clements WL, Schrohenloher RECRP, purification by affinity chromatography and physiochemical characterisation. J Immunol Meth 1978; 23: 285-295.
38. Sutterwala FS, Noel GJ, Clynes R, Mosser DM. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997; 185: 1977-1985.
39. Culley FJ, Thomson M, Raynes JG. C-reactive protein increases C3 deposition on Leishmania donovani promastigotes in human serum. Biochem Soc Trans 1997; 25: 286S.
40. Tebo JM, Mortensen RF. Characterisation and isolation of a CRP receptor from the human monocytic cell line U937. J Immunol 1990; 144: 231-238.
41. Zhong W, Zen Q, Tebo J, Schlottmann K, Coggeeshall M, Mortensen RF. Effect of human CRP on chemokine and chemotactic factor-induced chemotaxis and signalling. J Immunol 1998; 161: 2533-2540.
42. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999; 42: 23-30.
43. Murphy TM, Baum LL, Beaman KD. Extrahepatic transcription of human C-reactive protein. J Exp Med 1991; 173: 495-498.
44. Ghalib HW, Piuvezam MR, Skeiky YA et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1995; 92: 324-329.
45. Ghalib HW, Whittle JA, Kubin M et al. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol 1995; 154: 4623-4629.
46. Wilson ME, Sandor M, Blum AM et al. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J Immunol 1996; 156: 2231-2239.